If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Marketing Medicine & Life Sciences
Gram-Positive Bacteria Medicine & Life Sciences
Gram-Negative Bacteria Medicine & Life Sciences
cefpirome Medicine & Life Sciences
Streptococcus pneumoniae Medicine & Life Sciences
Peptostreptococcus Medicine & Life Sciences
Staphylococcus haemolyticus Medicine & Life Sciences
Haemophilus influenzae Medicine & Life Sciences

Research Output 1999 2003

  • 9 Citations
  • 2 h-Index
  • 9 Article

Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates: II. Gram-negative bacteria

Igari, J., Oguri, T., Hiramatsu, N., Akiyama, K. & Koyama, T., Oct 2003, In : Japanese Journal of Antibiotics. 56, 5, p. 458-496 39 p.

Research output: Contribution to journalArticle

Marketing
Gram-Negative Bacteria
cefpirome
Enterobacter cloacae
Imipenem

Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates: I. Gram-positive bacteria

Igari, J., Oguri, T., Hiramatsu, N., Akiyama, K. & Koyama, T., Oct 2003, In : Japanese Journal of Antibiotics. 56, 5, p. 437-457 21 p.

Research output: Contribution to journalArticle

Gram-Positive Bacteria
Marketing
Penicillins
Streptococcus pneumoniae
Staphylococcus epidermidis

Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001 - I. Gram-positive bacteria

Suzuki, Y., Nishinari, C., Endo, H., Hiramatsu, N., Akiyama, K. & Koyama, T., Aug 2003, In : Japanese Journal of Antibiotics. 56, 4, p. 294-308 15 p.

Research output: Contribution to journalArticle

Gram-Positive Bacteria
Peptostreptococcus
Staphylococcus haemolyticus
Streptococcus pneumoniae
Cefoperazone

Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001 - II. Gram-negative bacteria

Suzuki, Y., Nishinari, C., Endo, H., Hiramatsu, N., Akiyama, K. & Koyama, T., Aug 2003, In : Japanese Journal of Antibiotics. 56, 4, p. 309-335 27 p.

Research output: Contribution to journalArticle

Gram-Negative Bacteria
Haemophilus influenzae
Citrobacter koseri
Morganella morganii
Providencia

Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates - I. Gram-positive bacteria

Igari, J., Oguri, T., Hiramatsu, N., Akiyama, K. & Koyama, T., 2002, In : Japanese Journal of Antibiotics. 55, 1, p. 1-21 21 p.

Research output: Contribution to journalArticle

Gram-Positive Bacteria
Marketing
Enterococcus faecalis
cefpirome
Staphylococcus haemolyticus